Aerie Pharma (AERI) Misses Q1 EPS by 18c

Aerie Pharma (NASDAQ: AERI) reported Q1 EPS of ($1.05), $0.18 worse than the analyst estimate of ($0.87).

As of March 31, 2018, Aerie had cash, cash equivalents and investments of $334.0 million.

For earnings history and earnings-related data on Aerie Pharma (AERI) click here.

You May Also Be Interested In

• uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
• BofA Securities Reiterates Buy Rating on NVIDIA (NVDA)
• Citi upgrades Bath & Body Works to Buy with $25 price target